ESR1 and breast carcinoma: TNBC exhibits a unique molecular profile due to a lack of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression with distant metastasis potential, aggressive behavior, short overall survival, and lower 5-year relative survival rate compared to other breast cancer subtypes [1–3].